Was your mother right - Do we always need to close the door?

Circulation

Volumn 106, Issue 9, 2002, Pages 1034-1036

  Holmes Jr , David R ^a   Cabalka, Allison ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; WARFARIN;

ANTICOAGULANT THERAPY; CATHETER; CLINICAL TRIAL; EDITORIAL; HEART ATRIUM SEPTUM DEFECT; HEART RIGHT LEFT SHUNT; HUMAN; MAJOR CLINICAL STUDY; MULTICENTER STUDY; PRIORITY JOURNAL; STROKE; SURGICAL APPROACH; THROMBOEMBOLISM; TRANSESOPHAGEAL ECHOCARDIOGRAPHY;

AGE FACTORS; AGED; ANTICOAGULANTS; CARDIAC SURGICAL PROCEDURES; CAROTID ARTERY DISEASES; CASE-CONTROL STUDIES; CAUSALITY; CEREBROVASCULAR ACCIDENT; COMORBIDITY; ECHOCARDIOGRAPHY, TRANSESOPHAGEAL; HEART SEPTAL DEFECTS, ATRIAL; HUMANS; INTRACRANIAL EMBOLISM; META-ANALYSIS; MIDDLE AGED; ODDS RATIO; PATIENT SELECTION; PLATELET AGGREGATION INHIBITORS; PROSTHESES AND IMPLANTS; RECURRENCE; RISK;

EID: 0037183650     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.0000029818.65521.A9     Document Type: Editorial

References (14)

1. Trapped thrombus in a patent foramen ovale
2. Surgical treatment of impending paradoxical embolism through patent foramen ovale
3. Interatrial septal abnormalities and stroke A meta-analysis of case control studies
4. Atrial septal aneurysm and patent foramen ovale as risk factors for cryptogenic stroke in patients less than 55 years of age. A study using transesophageal echocardiography
5. Recurrent cerebrovascular events associated with patent foramen ovale, atrial septal aneurysm, or both
6. Effect of medical treatment in stroke patients with patent foramen ovale
7. Stroke recurrence in patients with patent foramen ovale
8. Patent foramen ovale and recurrent stroke
9. Surgical closure of patent foramen ovale in cryptogenic stoke patients
10. Surgical patent foramen ovale closure for prevention of paradoxical embolism-related cerebrovascular ischemic events
11. Systematic closure of patent foramen ovale in selected patients with arteriovascular events due to paradoxical embolism
12. Closure of patent foramen ovale for paradoxical emboli: Intermediate-term risk of recurrent Neurological events following transcatheter device placement
13. Percutaneous transcatheter closure of patent foramen ovale in patients with paradoxical embolism
14. Percutaneous closure of patent foramen ovale in patients with paradoxical embolism. Long-term risk of recurrent thromboembolic events